Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs

References

• Baek IH, Kim MS. 2012. Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions. Chem Pharm Bull. 60:1468–1473.
   Google Scholar
• Chauhan B, Shimpi S, Paradkar A. 2005. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur J Pharm Sci. 26:219–230.
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. 2008. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 7:771–782.
   PubMed Web of Science ®Google Scholar
• Friedrich H, Fussnegger B, Kolter K, Bodmeier R. 2006. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur J Pharm Biopharm. 62:171–177.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, Taylor LS. 2012. Understanding polymer properties important for crystal growth inhibition—Impact of chemically diverse polymers on solution crystal growth of ritonavir. Crystal Growth Des. 12:3133–3143.
   Web of Science ®Google Scholar
• Jia Z, Lin P, Xiang Y, Wang X, Wang J, Zhang X, Zhang Q. 2011. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. Eur J Pharm Biopharm. 79:126–134.
   PubMed Web of Science ®Google Scholar
• Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ. 2008. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 69:454–465.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ. 2011. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process. Int J Nanomedicine. 6:2997–3009.
   PubMed Web of Science ®Google Scholar
• Kinnari P, Mäkilä E, Heikkilä T, Salonen J, Hirvonen J, Santos HA. 2011. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int J Pharm. 414:148–156.
   PubMed Web of Science ®Google Scholar
• Kojima T, Higashi K, Suzuki T, Tomono K, Moribe K, Yamamoto K. 2012. Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO. Pharm Res. 29:2777–2791.
   PubMed Web of Science ®Google Scholar
• Limnell T, Santos HA, Mäkilä E, Heikkilä T, Salonen J, Murzin DY, et al. 2011. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci. 100:3294–3306.
   PubMed Web of Science ®Google Scholar
• Linn M, Collnot EM, Djuric D, Hempel K, Fabian E, Kolter K, Lehr CM. 2012. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 45:336–343.
   PubMed Web of Science ®Google Scholar
• Mamaeva V, Sahlgren C, Lindén M. 2012. Mesoporous silica nanoparticles in medicine-Recent advances. Adv Drug Deliv Rev. doi:10.1016/j.addr.2012.07.018.
   Web of Science ®Google Scholar
• Miura H, Kanebako M, Shirai H, Nakao H, Inagi T, Terada K. 2011. Influence of particle design on oral absorption of poorly water- soluble drug in a silica particle-supercritical fluid system. Chem Pharm Bull. 59:686–691.
   Google Scholar
• Nagy ZK, Balogh A, Vajna B, Farkas A, Patyi G, Kramarics A, Marosi G. 2012. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci. 101:322–332.
   PubMed Web of Science ®Google Scholar
• Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, Williams RO III. 2008. Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing. Pharm Res. 25:167–175.
   PubMed Web of Science ®Google Scholar
• Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JA, et al. 2010. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials. 31:5564–5574.
   PubMed Web of Science ®Google Scholar
• Product Information, Degussa. Available at: http://www.aerosil.com. Accessed on 18 Dec 2012.
   Google Scholar
• Van Eerdenbrugh B, Van Speybroeck M, Mols R, Houthoofd K, Martens JA, Froyen L, et al. 2009. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance. Eur J Pharm Sci. 38:270–278.
   PubMed Web of Science ®Google Scholar
• Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. 2010. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 6:1952–1967.
   PubMed Web of Science ®Google Scholar
• Wang L, Cui FD, Sunada H. 2006. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method. Chem Pharm Bull. 54:37–43.
   PubMed Web of Science ®Google Scholar
• Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR, Zhang Q. 2011. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm. 419:339–346.
   PubMed Web of Science ®Google Scholar
• Warren DB, Benameur H, Porter CJ, Pouton CW. 2010. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility. J Drug Target. 18:704–731.
   PubMed Web of Science ®Google Scholar
• Wen H, Morris KR, Park K. 2005. Hydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophen. J Colloid Interface Sci. 290:325–335.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang J, Bai X, Jiang T, Zhang Q, Wang S. 2012. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm. 9:505–513.
   PubMed Web of Science ®Google Scholar